Sonic Healthcare Limited (AU:SHL)
ASX:SHL
Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.56
-AU$0.19(-0.67%)
At close: 4:00 PM EST
AU$20.56
-AU$0.19(-0.67%)
Day’s Range― - ―
52-Week RangeAU$18.26 - AU$29.24
Previous CloseN/A
Volume607.50K
Average Volume (3M)1.62M
Market Cap
AU$9.76B
Enterprise ValueAU$16.99B
Total Cash (Recent Filing)AU$557.12M
Total Debt (Recent Filing)AU$7.34B
Price to Earnings (P/E)18.2
Beta0.72
Next Earnings
Aug 20, 2026EPS Estimate
0.66Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)1.11
Shares Outstanding494,237,950
10 Day Avg. Volume1,694,025
30 Day Avg. Volume1,619,425
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.55
Price to Sales (P/S)1.34
P/FCF Ratio13.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$23.20Price Target Upside12.84% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)1.21
Revenue Forecast (FY)AU$10.96B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSonic's FCF growth and a 2.53x operating-cash-to-net-income conversion signal durable cash-generation capacity. This supports the progressive dividend policy, funds organic capex and integration spending, and provides a buffer for refinancing or buybacks while preserving strategic optionality.
Maintained EBITDA Guidance And Margin ImprovementMaintaining FY EBITDA guidance while delivering ~5% organic growth and ~30bp margin expansion demonstrates operational resilience and underlying operating leverage across divisions. These trends support sustainable earnings power even as management navigates integration and market headwinds.
Disciplined Capital Management And Balance-sheet HeadroomA targeted debt-cover metric, ~US$1bn headroom and active capital actions (dividend, sale-and-leaseback, potential buybacks) indicate disciplined allocation. This structural flexibility supports acquisitions, integration investment and shareholder returns without abandoning an investment-grade posture.
Bears Say
U.S. Margin Pressure And RestructuringPersisting U.S. margin weakness and the need to rationalize anatomical pathology practices point to structural market and cost challenges. Restructuring costs and slower recovery of U.S. volumes can depress near-to-medium-term margins and limit cash conversion in Sonic's largest higher-cost geography.
Higher Leverage From Acquisitions And Property SpendingAcquisition and property-related spending has increased net debt, raising leverage versus prior levels. With interest expense guided ~15% higher and some below-EBITDA spend elevated, elevated leverage could pressure flexibility for further M&A or distribution if cash generation softens.
Working-capital And Billing DisruptionThe Change Healthcare incident created prolonged collections headwinds and inflated receivables, deferring expected revenue-collection benefits into FY2027. Prolonged working-capital strain reduces available cash, raises short-term funding needs and complicates execution of capital programs until fully resolved.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.26 and its highest was AU$29.24 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$9.76B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 71 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.5 earnings per share for the quarter, missing the consensus estimate of AU$0.527 by -AU$0.027.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.45 which represents an annual dividend yield of 4.69%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.66.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.5 in its last earnings report, missing expectations of AU$0.527. Following the earnings report the stock price went up 9.887%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$23.20 (12.84% Upside)
AU$23.20 (12.84% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.99%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$23.20
▲(12.84% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---